284 related articles for article (PubMed ID: 33017752)
1. Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence.
Wilson LL; Harris HM; Eans SO; Brice-Tutt AC; Cirino TJ; Stacy HM; Simons CA; León F; Sharma A; Boyer EW; Avery BA; McLaughlin JP; McCurdy CR
Drug Alcohol Depend; 2020 Nov; 216():108310. PubMed ID: 33017752
[TBL] [Abstract][Full Text] [Related]
2. Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal.
Wilson LL; Chakraborty S; Eans SO; Cirino TJ; Stacy HM; Simons CA; Uprety R; Majumdar S; McLaughlin JP
Cell Mol Neurobiol; 2021 Jul; 41(5):1131-1143. PubMed ID: 33433723
[TBL] [Abstract][Full Text] [Related]
3. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
4. In vivo effects of μ-opioid receptor agonist/δ-opioid receptor antagonist peptidomimetics following acute and repeated administration.
Anand JP; Kochan KE; Nastase AF; Montgomery D; Griggs NW; Traynor JR; Mosberg HI; Jutkiewicz EM
Br J Pharmacol; 2018 Jun; 175(11):2013-2027. PubMed ID: 29352503
[TBL] [Abstract][Full Text] [Related]
5. Effects of ATPM-ET, a novel κ agonist with partial μ activity, on physical dependence and behavior sensitization in mice.
SUN JF; WANG YH; LI FY; LU G; TAO YM; CHENG Y; CHEN J; XU XJ; CHI ZQ; NEUMEYER JL; ZHANG A; LIU JG
Acta Pharmacol Sin; 2010 Dec; 31(12):1547-52. PubMed ID: 21102484
[TBL] [Abstract][Full Text] [Related]
6. Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of
Gerak LR; Minervini V; Latham E; Ghodrati S; Lillis KV; Wooden J; Disney A; Husbands SM; France CP
J Pharmacol Exp Ther; 2019 Nov; 371(2):507-516. PubMed ID: 31439807
[TBL] [Abstract][Full Text] [Related]
7. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
8. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
9. In vivo characterization of MMP-2200, a mixed δ/μ opioid agonist, in mice.
Lowery JJ; Raymond TJ; Giuvelis D; Bidlack JM; Polt R; Bilsky EJ
J Pharmacol Exp Ther; 2011 Mar; 336(3):767-78. PubMed ID: 21118955
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Gβγ-subunit signaling potentiates morphine-induced antinociception but not respiratory depression, constipation, locomotion, and reward.
Hoot MR; Sypek EI; Reilley KJ; Carey AN; Bidlack JM; McLaughlin JP
Behav Pharmacol; 2013 Apr; 24(2):144-52. PubMed ID: 23412114
[TBL] [Abstract][Full Text] [Related]
11. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
Crain SM; Shen KF
Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
[TBL] [Abstract][Full Text] [Related]
12. Fecal microbiota transplantation and antibiotic treatment attenuate naloxone-precipitated opioid withdrawal in morphine-dependent mice.
Thomaz AC; Iyer V; Woodward TJ; Hohmann AG
Exp Neurol; 2021 Sep; 343():113787. PubMed ID: 34153321
[TBL] [Abstract][Full Text] [Related]
13. The behavioral effects of a mixed efficacy antinociceptive peptide, VRP26, following chronic administration in mice.
Anand JP; Boyer BT; Mosberg HI; Jutkiewicz EM
Psychopharmacology (Berl); 2016 Jul; 233(13):2479-87. PubMed ID: 27117141
[TBL] [Abstract][Full Text] [Related]
14. Behavioral and neurochemical characterization of kratom (Mitragyna speciosa) extract.
Stolt AC; Schröder H; Neurath H; Grecksch G; Höllt V; Meyer MR; Maurer HH; Ziebolz N; Havemann-Reinecke U; Becker A
Psychopharmacology (Berl); 2014 Jan; 231(1):13-25. PubMed ID: 23846544
[TBL] [Abstract][Full Text] [Related]
15. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
[TBL] [Abstract][Full Text] [Related]
16. Prohormone convertase 2 (PC2) null mice have increased mu opioid receptor levels accompanied by altered morphine-induced antinociception, tolerance and dependence.
Lutfy K; Parikh D; Lee DL; Liu Y; Ferrini MG; Hamid A; Friedman TC
Neuroscience; 2016 Aug; 329():318-25. PubMed ID: 27208618
[TBL] [Abstract][Full Text] [Related]
17. Inverse agonists and neutral antagonists at mu opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence.
Wang D; Raehal KM; Bilsky EJ; Sadée W
J Neurochem; 2001 Jun; 77(6):1590-600. PubMed ID: 11413242
[TBL] [Abstract][Full Text] [Related]
18. LPK-26, a novel kappa-opioid receptor agonist with potent antinociceptive effects and low dependence potential.
Tao YM; Li QL; Zhang CF; Xu XJ; Chen J; Ju YW; Chi ZQ; Long YQ; Liu JG
Eur J Pharmacol; 2008 Apr; 584(2-3):306-11. PubMed ID: 18353307
[TBL] [Abstract][Full Text] [Related]
19. Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine.
Hemby SE; McIntosh S; Leon F; Cutler SJ; McCurdy CR
Addict Biol; 2019 Sep; 24(5):874-885. PubMed ID: 29949228
[TBL] [Abstract][Full Text] [Related]
20. The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics.
Raehal KM; Bohn LM
Neuropharmacology; 2011 Jan; 60(1):58-65. PubMed ID: 20713067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
